Fukuda Denshi (6960) Q1 2027 earnings summary

Executive summary

• Revenue for Q1 FY2027 was ¥30,985 million, up 2.0% year-over-year, with operating profit at ¥4,592 million, up 9.9%, and net profit attributable to shareholders at ¥3,079 million, up 8.8%.

• The business environment remains uncertain due to global geopolitical risks, but the domestic economy is on a moderate recovery path.

• Medical industry trends include digital transformation and regional healthcare collaboration.

Financial highlights

• Gross profit for Q1 FY2027 was ¥16,814 million, with a gross margin of 54.3%.

• Operating profit margin improved to 14.8% from 13.8% year-over-year.

• Comprehensive income surged to ¥6,920 million, up 115.7% year-over-year.

• EPS for Q1 FY2027 was ¥113.97, up from ¥100.87 in the prior year.

Outlook and guidance

• Full-year FY2027 revenue forecast is ¥142,000 million (+1.6% YoY), with operating profit of ¥25,500 million (–4.2%), and net profit of ¥17,700 million (–5.8%).

• No change to previously announced full-year guidance; Q1 results were in line with expectations.

• The company notes that Q4 is typically the peak sales period.